| Literature DB >> 34858918 |
Hao Gao1, Difan Guo1, Jing Wu2, Qingting Zhao1, Lina Li3.
Abstract
Introduction: On December 31, 2020, the Chinese government announced that the domestic coronavirus disease-2019 (COVID-19) vaccines have obtained approval for conditional marketing and are free for vaccination. This release drove the attention of the public and intense debates on social media, which reflected public attitudes to the domestic vaccine. This study examines whether the public concerns and public attitudes to domestic COVID-19 vaccines changed after the official announcement.Entities:
Keywords: COVID-19; China; official announcement; public attitude; vaccination; vaccines
Mesh:
Substances:
Year: 2021 PMID: 34858918 PMCID: PMC8632040 DOI: 10.3389/fpubh.2021.723015
Source DB: PubMed Journal: Front Public Health ISSN: 2296-2565
Figure 1Design of this study.
The degree centrality of keywords in two semantic networks.
|
|
| |||
|---|---|---|---|---|
|
|
|
|
| |
| 1 | Vaccines | 44,683 | Vaccines | 49,221 |
| 2 | COVID-19 | 43,694 | COVID-19 | 48,507 |
| 3 | Vaccination | 16,846 | Vaccination | 40,141 |
| 4 | China | 8,729 | Production capacity | 19,896 |
| 5 | Effectiveness | 4,398 | Large-scale | 9,121 |
| 6 | Safe | 4,184 | Free | 8,159 |
| 7 | Safety | 4,157 | Break | 5,083 |
| 8 | Effective | 3,823 | China | 4,572 |
| 9 | Appreciate | 3,812 | America | 4,521 |
| 10 | Free | 3,616 | Emphasis | 4,430 |
| 11 | Highly | 3,608 | Crowd | 4,213 |
| 12 | Staff | 2,908 | Nationwide | 4,156 |
| 13 | Crowd | 2,815 | Satisfy | 3,850 |
| 14 | Virus | 2,781 | Virus | 3,685 |
| 15 | Precedence | 2,733 | Deliberately | 3,502 |
Figure 2Semantic network graph of domestic COVID-19 vaccines before approved for marketing.
Figure 3Semantic network graph of domestic COVID-19 vaccines after approved for marketing.
Correlation and regression analysis of two semantic networks.
|
|
| |
|---|---|---|
| Obs Value | 0.931 | 0.592 |
P = 0.003 < 0.05
P = 0.000 < 0.001.
Results of sentiment analysis.
|
|
|
|
|
|
| |
|---|---|---|---|---|---|---|
| Sample 1 | Positive | 31,113 | 51.75% | Good | 107,517 | 49.10% |
| Happy | 23,399 | 10.68% | ||||
| Neutral | 11,639 | 19.36% | Surprise | 13,330 | 6.09% | |
| Disgust | 13,207 | 6.03% | ||||
| Negative | 17,370 | 28.89% | Fear | 16,351 | 7.47% | |
| Anger | 16,342 | 7.46% | ||||
| Sadness | 28,845 | 13.17% | ||||
| Sample 2 | Positive | 48,893 | 61.61% | Good | 28,2101 | 55.24% |
| Happy | 51,365 | 10.06% | ||||
| Neutral | 7,365 | 9.28% | Surprise | 30,369 | 5.95% | |
| Disgust | 22,987 | 4.50% | ||||
| Negative | 23,101 | 29.11% | Fear | 46,655 | 9.14% | |
| Anger | 26,083 | 5.11% | ||||
| Sadness | 51,094 | 10.00% |
High-frequency words of “good” and “fear” in the two samples.
|
|
| |||||||
|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
| |
| 1 | Vaccines | 1,539 | Vaccines | 1,491 | Vaccines | 1,688 | Vaccines | 1,613 |
| 2 | COVID-19 | 1,271 | COVID-19 | 1,284 | COVID-19 | 1,114 | COVID-19 | 1,311 |
| 3 | Vaccination | 577 | China | 693 | Vaccination | 941 | Vaccination | 798 |
| 4 | Marketing | 308 | Medicament | 527 | Free | 908 | China | 603 |
| 5 | China | 281 | Safe | 518 | Large-scale | 320 | Effect | 332 |
| 6 | Hope | 212 | Trial | 515 | Production Capacity | 294 | Pfizer | 302 |
| 7 | Clinic | 183 | Clinic | 514 | Nationwide | 169 | Side-effect | 293 |
| 8 | Nation | 179 | Vaccination | 496 | Thank | 169 | Domestic | 271 |
| 9 | Success | 165 | Precedence | 332 | Government | 143 | Safe | 224 |
| 10 | Domestic | 161 | Crowd | 324 | Satisfy | 139 | America | 218 |